BjornE.OskarssonMDFAAN
Neurology • Jacksonville, FLNeuromuscular Medicine
Associate Professor of Neurology Consultant Neurology Director ALS Clinic Mayo Clinic Jacksonville
Dr. Oskarsson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4500 San Pablo Rd S
Jacksonville, FL 32224Phone+1 904-953-2000Fax+1 904-953-0757
Summary
- I am a Neurologist working on clinical care of people with ALS and clinical research for better treatments of ALS for the future.
Education & Training
University of ColoradoFellowship, Neuromuscular Medicine (Neurology), 2004 - 2006- University of ColoradoResidency, Neurology, 2001 - 2004
- University of ColoradoInternship, Internal Medicine, 2000 - 2001
Lund University Faculty of MedicineClass of 1999
Certifications & Licensure
CA State Medical License 2008 - Present
FL State Medical License 2016 - 2025
CO State Medical License 2004 - 2009- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- Fellow American Academy of Neurology, 2016
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- DNA, Blood and Skin Cell Repository for Research on ALS and Related Neurodegenerative Disorders at Mayo Clinic Florida Start of enrollment: 2012 Sep 01
- Mexiletine for the Treatment of Muscle Cramps in ALS Start of enrollment: 2013 May 01
- Use of (-)-Epicatechin in the Treatment of Becker Muscular Dystrophy (Pilot Study) Start of enrollment: 2013 May 01
- Join now to see all
Publications & Presentations
PubMed
- 36 citationsClinical characteristics of a large cohort of US participants enrolled in the National Amyotrophic Lateral Sclerosis (ALS) Registry, 2010–2015Jaime Raymond, Bjorn Oskarsson, Paul Mehta, Kevin Horton
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2019-05-26 - 37 citationsTwo FTD-ALS genes converge on the endosomal pathway to induce TDP-43 pathology and degeneration.Wei Shao, Tiffany W Todd, Yanwei Wu, Caroline Y Jones, Jimei Tong
Science. 2022-10-07 - 206 citationsTDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A.X Rosa Ma, Mercedes Prudencio, Yuka Koike, Sarat C Vatsavayai, Garam Kim
Nature. 2022-03-01
Journal Articles
- Poly(GR) Impairs Protein Translation and Stress Granule Dynamics in C9orf72-Associated Frontotemporal Dementia and Amyotrophic Lateral SclerosisDennis W Dickson, Bjorn Oskarsson, Nature
Press Mentions
Toward Clinical Trials for One Type of ALSJanuary 2nd, 2019
Flex Pharma Investigates FLX-787 as Treatment for Cramps in ALS PatientsAugust 2nd, 2017
FDA Clears Flex Pharma's FLX-787 to Commence US Phase 2 Trial in ALS Under INDAugust 1st, 2017- Join now to see all
Professional Memberships
- Member
- Fellow
Other Languages
- Swedish
External Links
- Mayo biohttps://www.mayoclinic.org/biographies/oskarsson-bjorn-e-m-d/bio-20257831
- Refer a patienthttp://www.mayoclinic.org/medical-professionals/provider-relations/refer-a-patient
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
